Thu, Jun. 9, 10:44 AM
- Shares of Hershey (NYSE:HSY) are up 1.7% with some traders chatting up a Nestle (OTCPK:NSRGY, OTCPK:NSRGF) buyout scenario.
- Nestle is currently third in the North America chocolate market behind Hershey and Mars.
- A Nestle-Hershey combination would likely lead to some asset sales, similar to the MegaBrew deal maneuvers that Anheuser-Busch InBev and SABMiller had to work out to appease regulators.
Aug. 14, 2015, 1:44 PM
- Nestle (OTCPK:NSRGY, OTCPK:NSRGF) or General Mills (GIS +0.5%) could make a run at Mondelez International (MDLZ +0.9%) with Berkshire Hathaway and 3G effectively taking themselves out of the bidding process for a few years due to the Kraft-Heinz merger, speculates The Deal.
- A buyer of Mondelez will have to be heavy hitter due to the company's estimated enterprise value of +$90B. PepsiCo (PEP +0.3%) fits the bill and has Nelson Peltz backing the play, but has a board and CEO seemingly uninterested.
Jul. 20, 2015, 11:53 AM
- There's been minor spike in General Mills (NYSE:GIS) from negative territory after some chatter on a Nestle (OTCPK:NSRGF, OTCPK:NSRGY) buyout circulates.
- Talk on a combination between food giants has been in the background ever since the gigantic Heinz-Kraft merger. The usual list of suspects includes Kellogg, Campbell Soup, and Hormel along with General Mills.
- GIS is +0.2% to trade less than a dollar from its 52-week high.
- Previously: Handicapping 3G Capital's next food play (Mar. 26 2015)
- Previously: General Mills CEO talks M&A (Jul. 15 2015)
Feb. 3, 2014, 7:29 AM
- Maybe boosting speculation about Bill Stiritz's plans for Herbalife (HLF), Post Holdings (POST) expands its efforts in the active nutrition area with the acquisitions of the PowerBar and Musashi brands from Nestle (NSRGY).
- Combining these products with Post's existing portfolio to form a Active Nutrition Group, Post expects the unit will have annualized revenue near $550M.
- It should be noted, Stiritz's holdings of Herbalife are strictly as a private investor.
- From Barron's Roundtable: Gabelli says Stiritz to do for Post what he did for Ralston Purina.
- Earlier: HLF ups guidance and buyback
- HLF +3.3% premarket
Jul. 10, 2013, 12:31 PM
Mead Johnson Nutrition (MJN +3.8%) finally caves-in to pressure and says it will reduce the ex-factory price of its main products by 7% - 15% as of July 16. China's Bureau of Price Supervision and Anti-Monopoly recently launched an investigation into price-fixing in the infant formula market, prompting other firms such as Abbott Labs (ABT), Nestle (NSRGY.PK) and Danone to already reduce prices.| Jul. 10, 2013, 12:31 PM
Jul. 9, 2013, 2:48 PM
Allergan (AGN +1.8%) ticks higher today on speculation that recent weakness in the stock could lead to a potential takeover. The shares have dipped by 28% since mid-April on concerns over delays in drug studies and generic competition. But AGN could be a good fit for the likes of a GlaxoSmithKline (GSK,), who already licenses Botox from AGN, or Merck (MRK), who produces comparable eye-care products. Leerink Swann notes also that Nestle (NSRGY.PK) could be a good fit for merging its skin-care business.| Jul. 9, 2013, 2:48 PM
Jul. 2, 2013, 2:27 PM
Shares of Mead Johnson Nutrition (MJN -6.1%) responds to reports that it, as well as other companies, are under investigation in China for possible antitrust violations. The company says it's committed to providing high-quality and safe products at a good value for consumers in China and throughout the world, and it's fully cooperating with the Chinese government antitrust review of resale prices in the infant formula market and will provide information in response to inquiries received from government officials.| Jul. 2, 2013, 2:27 PM
Feb. 20, 2013, 12:09 PM
Shares of Green Mountain Coffee Roasters (GMCR +1.8%) show extra volatility with the rumor mill churning again on interest from Nestle (NSRGY.PK) in the Keurig maker. Though the mix of a U.S-centric GMCR and global giant Nestle makes sense on some fronts, there's nothing concrete on a deal and the prospect for a bid is mainly post-Heinz M&A scuttlebutt.| Feb. 20, 2013, 12:09 PM | 6 Comments
Apr. 20, 2012, 10:31 AM
Danone (DANOY.PK -2.3%), bidding along with Mead Johnson (MJN +1.8%), reportedly raises its offer for Pfizer's (PFE +1.2%) infant nutrition business to nearly $11B. Analysts say Danone needs the business or it will face a problem of how to expand. Nestle (NSRGY.PK +0.2%) earlier this week was seen closing in on a deal to buy the Pfizer unit for at least $9B.| Apr. 20, 2012, 10:31 AM | 1 Comment
Apr. 19, 2012, 5:44 PM
Jamba (JMBA) says it will buy the product formulation and intellectual property for its Jamba All-Natural Energy Drink from Nestle (NSRGY.PK) as part of its consumer products expansion plan. Jamba had collaborated with Nestle USA to launch the drink in the Northeast but now plans to expand its availability outside of the region. Shares -2.6% AH.| Apr. 19, 2012, 5:44 PM
Apr. 18, 2012, 9:57 AMMead Johnson Nutrition (MJN -2.6%) and Danone (DANOY.PK) look like the losers for Pfizer's (PFE +0.5%) baby formula business, as PFE reportedly is near a deal to sell the unit to Nestle (NSRGY.PK) for at least $9B. MJN and Danone were said to have teamed up for a bid that may have been as high as $10B. | Apr. 18, 2012, 9:57 AM